Tumor necrosis factor (TNF)-alpha and interleukin (IL)-1beta down-regulate intercellular adhesion molecule (ICAM)-2...

Area of Science:

• Immunology
• Cell Biology
• Molecular Biology

Background:

• Leukocyte recruitment is vital for inflammation.
• Endothelial adhesion molecules like E-selectin and ICAM-1 are upregulated by inflammatory stimuli.
• The role of ICAM-2, a ligand for beta2 integrins, in inflammation is not well understood.

Purpose of the Study:

• To investigate the effects of TNF-alpha and IL-1beta on ICAM-2 expression in human umbilical vein endothelial cells (HUVECs).

Main Methods:

• HUVECs were treated with TNF-alpha and IL-1beta for 24 hours.
• ICAM-2 surface expression was measured.
• ICAM-2 mRNA levels and promoter activity were assessed.
• Immunocytochemistry was used to visualize ICAM-2 localization.

Main Results:

• TNF-alpha and IL-1beta significantly reduced ICAM-2 surface expression and mRNA levels in HUVECs.
• Cytokine treatment also decreased ICAM-2 promoter activity.
• Interferon-gamma did not affect ICAM-2 expression.
• ICAM-2 expression, typically at cell junctions, was reduced upon cytokine treatment.

Conclusions:

• Inflammatory cytokines TNF-alpha and IL-1beta inhibit ICAM-2 transcription and reduce its surface expression on endothelial cells.
• This suggests a regulatory role for ICAM-2 in endothelial cell function during inflammation.
• The downregulation occurs despite the absence of known cytokine-responsive elements in the ICAM-2 promoter.